Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis

Rajashekhar Kanchanapally,1 Sachin Kumar Deshmukh,1 Suhash Reddy Chavva,1 Nikhil Tyagi,1 Sanjeev Kumar Srivastava,1 Girijesh Kumar Patel,1 Ajay Pratap Singh,1,2 Seema Singh1,2 1Department of Oncologic Sciences, Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA; 2Departme...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kanchanapally R, Deshmukh SK, Chavva SR, Tyagi N, Srivastava SK, Patel GK, Singh AP, Singh S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/28936b5729cd4464aced6e59be9a66b9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:28936b5729cd4464aced6e59be9a66b9
record_format dspace
spelling oai:doaj.org-article:28936b5729cd4464aced6e59be9a66b92021-12-02T02:27:22ZDrug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis1178-2013https://doaj.org/article/28936b5729cd4464aced6e59be9a66b92019-01-01T00:00:00Zhttps://www.dovepress.com/drug-loaded-exosomal-preparations-from-different-cell-types-exhibit-di-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Rajashekhar Kanchanapally,1 Sachin Kumar Deshmukh,1 Suhash Reddy Chavva,1 Nikhil Tyagi,1 Sanjeev Kumar Srivastava,1 Girijesh Kumar Patel,1 Ajay Pratap Singh,1,2 Seema Singh1,2 1Department of Oncologic Sciences, Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA; 2Department of Biochemistry and Molecular Biology, College of Medicine, University of South Alabama, Mobile, AL 36688, USA Background: Despite tremendous advancement, cancer still remains one of the leading causes of death worldwide. Inefficiency of current drug delivery regimens is one important factor that limits the therapeutic efficacy of existing drugs, thus contributing to cancer mortality. To address this limitation, synthetic nanotechnology-based delivery systems have been developed; however, they raise concern of inducing adverse immunogenic reactions. Exosomes (Exos) are nonimmunogenic nano-sized vesicles that have received significant attention as efficient drug delivery system. Methods: Drug loading in Exos were achieved by incubating different cell types viz pancreatic cancer cells (PCCs), pancreatic stellate cells (PSCs), and macrophages (MØs) with Doxorubicin (DOX). Differential ultracentrifugation was performed to isolate exosome and their size was determined by dynamic light scattering analysis. The efficacy of drug packaging into Exos was evaluated by HPLC. Flow cytometry was performed to examine the apoptosis. Cell viability was determined using the WST-1 assay.Results: PCCs shed the most Exos and were the most efficient in drug loading followed by MØs and PSCs as examined by HPLC quantification. However, when compared for antitumor efficacy, MØ-derived Exos loaded with DOX (MØ-Exo-DOX) showed highest activity followed by PSCs and PCCs. Conclusion: These varying antitumor activities likely resulted from nondrug contents of Exos since we did not observe any significant differences in their uptake by the cancer cells. Altogether, our data suggest that donor cell-specific differences exist in Exos, which could influence their utility as drug carrier for therapeutic purposes. Keywords: exosome, macrophage, pancreatic cancer, drug delivery, doxorubicinKanchanapally RDeshmukh SKChavva SRTyagi NSrivastava SKPatel GKSingh APSingh SDove Medical PressarticleExosomemacrophagepancreatic cancerdrug deliverydoxorubicinMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 531-541 (2019)
institution DOAJ
collection DOAJ
language EN
topic Exosome
macrophage
pancreatic cancer
drug delivery
doxorubicin
Medicine (General)
R5-920
spellingShingle Exosome
macrophage
pancreatic cancer
drug delivery
doxorubicin
Medicine (General)
R5-920
Kanchanapally R
Deshmukh SK
Chavva SR
Tyagi N
Srivastava SK
Patel GK
Singh AP
Singh S
Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis
description Rajashekhar Kanchanapally,1 Sachin Kumar Deshmukh,1 Suhash Reddy Chavva,1 Nikhil Tyagi,1 Sanjeev Kumar Srivastava,1 Girijesh Kumar Patel,1 Ajay Pratap Singh,1,2 Seema Singh1,2 1Department of Oncologic Sciences, Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA; 2Department of Biochemistry and Molecular Biology, College of Medicine, University of South Alabama, Mobile, AL 36688, USA Background: Despite tremendous advancement, cancer still remains one of the leading causes of death worldwide. Inefficiency of current drug delivery regimens is one important factor that limits the therapeutic efficacy of existing drugs, thus contributing to cancer mortality. To address this limitation, synthetic nanotechnology-based delivery systems have been developed; however, they raise concern of inducing adverse immunogenic reactions. Exosomes (Exos) are nonimmunogenic nano-sized vesicles that have received significant attention as efficient drug delivery system. Methods: Drug loading in Exos were achieved by incubating different cell types viz pancreatic cancer cells (PCCs), pancreatic stellate cells (PSCs), and macrophages (MØs) with Doxorubicin (DOX). Differential ultracentrifugation was performed to isolate exosome and their size was determined by dynamic light scattering analysis. The efficacy of drug packaging into Exos was evaluated by HPLC. Flow cytometry was performed to examine the apoptosis. Cell viability was determined using the WST-1 assay.Results: PCCs shed the most Exos and were the most efficient in drug loading followed by MØs and PSCs as examined by HPLC quantification. However, when compared for antitumor efficacy, MØ-derived Exos loaded with DOX (MØ-Exo-DOX) showed highest activity followed by PSCs and PCCs. Conclusion: These varying antitumor activities likely resulted from nondrug contents of Exos since we did not observe any significant differences in their uptake by the cancer cells. Altogether, our data suggest that donor cell-specific differences exist in Exos, which could influence their utility as drug carrier for therapeutic purposes. Keywords: exosome, macrophage, pancreatic cancer, drug delivery, doxorubicin
format article
author Kanchanapally R
Deshmukh SK
Chavva SR
Tyagi N
Srivastava SK
Patel GK
Singh AP
Singh S
author_facet Kanchanapally R
Deshmukh SK
Chavva SR
Tyagi N
Srivastava SK
Patel GK
Singh AP
Singh S
author_sort Kanchanapally R
title Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis
title_short Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis
title_full Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis
title_fullStr Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis
title_full_unstemmed Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis
title_sort drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/28936b5729cd4464aced6e59be9a66b9
work_keys_str_mv AT kanchanapallyr drugloadedexosomalpreparationsfromdifferentcelltypesexhibitdistinctiveloadingcapabilityyieldandantitumorefficaciesacomparativeanalysis
AT deshmukhsk drugloadedexosomalpreparationsfromdifferentcelltypesexhibitdistinctiveloadingcapabilityyieldandantitumorefficaciesacomparativeanalysis
AT chavvasr drugloadedexosomalpreparationsfromdifferentcelltypesexhibitdistinctiveloadingcapabilityyieldandantitumorefficaciesacomparativeanalysis
AT tyagin drugloadedexosomalpreparationsfromdifferentcelltypesexhibitdistinctiveloadingcapabilityyieldandantitumorefficaciesacomparativeanalysis
AT srivastavask drugloadedexosomalpreparationsfromdifferentcelltypesexhibitdistinctiveloadingcapabilityyieldandantitumorefficaciesacomparativeanalysis
AT patelgk drugloadedexosomalpreparationsfromdifferentcelltypesexhibitdistinctiveloadingcapabilityyieldandantitumorefficaciesacomparativeanalysis
AT singhap drugloadedexosomalpreparationsfromdifferentcelltypesexhibitdistinctiveloadingcapabilityyieldandantitumorefficaciesacomparativeanalysis
AT singhs drugloadedexosomalpreparationsfromdifferentcelltypesexhibitdistinctiveloadingcapabilityyieldandantitumorefficaciesacomparativeanalysis
_version_ 1718402455405854720